Lulin Cheng

552 total citations
13 papers, 323 citations indexed

About

Lulin Cheng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lulin Cheng has authored 13 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lulin Cheng's work include Circular RNAs in diseases (5 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Lulin Cheng is often cited by papers focused on Circular RNAs in diseases (5 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Lulin Cheng collaborates with scholars based in China. Lulin Cheng's co-authors include Yarong Song, Yifei Xing, Yunxue Li, Xuexiang Li, Liang Chen, Fang Lv, Ying Yu, Dingheng Lu, Bing Liu and Bing Liu and has published in prestigious journals such as The FASEB Journal, Cell Death and Disease and Cellular Signalling.

In The Last Decade

Lulin Cheng

12 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lulin Cheng China	9	219	162	116	54	39	13	323
Huohui Ou China	10	280 1.3×	212 1.3×	97 0.8×	81 1.5×	23 0.6×	16	405
Shunsuke Misono Japan	11	271 1.2×	213 1.3×	68 0.6×	48 0.9×	20 0.5×	17	341
Pier‐Luc Clermont Canada	10	360 1.6×	154 1.0×	169 1.5×	65 1.2×	33 0.8×	15	477
Wei‐Jia Mo China	12	272 1.2×	208 1.3×	76 0.7×	47 0.9×	18 0.5×	30	352
Aiping Ding China	10	185 0.8×	88 0.5×	75 0.6×	89 1.6×	26 0.7×	20	293
Shinya Kidogami Japan	12	236 1.1×	114 0.7×	49 0.4×	66 1.2×	58 1.5×	26	321
Junqing Hou China	11	292 1.3×	280 1.7×	85 0.7×	58 1.1×	16 0.4×	25	428
Heping Kan China	12	290 1.3×	221 1.4×	72 0.6×	89 1.6×	35 0.9×	18	425
Yaqi Gan China	9	280 1.3×	173 1.1×	80 0.7×	61 1.1×	18 0.5×	10	360

Countries citing papers authored by Lulin Cheng

Since Specialization

Citations

This map shows the geographic impact of Lulin Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lulin Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lulin Cheng more than expected).

Fields of papers citing papers by Lulin Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lulin Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lulin Cheng. The network helps show where Lulin Cheng may publish in the future.

Co-authorship network of co-authors of Lulin Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Lulin Cheng. A scholar is included among the top collaborators of Lulin Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lulin Cheng. Lulin Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Li, Haoran, Kang Chen, Lulin Cheng, et al.. (2025). FAM111B enhances glycolysis and promotes metastasis of prostate cancer by upregulating LDHA. Neoplasia. 69. 101227–101227.

Liu, Chunyu, Liang Chen, Lulin Cheng, et al.. (2024). Protein phosphatase 1 regulatory subunit 15 A promotes translation initiation and induces G2M phase arrest during cuproptosis in cancers. Cell Death and Disease. 15(2). 149–149. 4 indexed citations

Liu, Chunyu, et al.. (2024). CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway. Cellular Signalling. 119. 111164–111164. 8 indexed citations

Liu, Chunyu, Liang Chen, Fang Lv, et al.. (2024). Hsa_circ_0001583 fuels bladder cancer metastasis by promoting staphylococcal nuclease and tudor domain containing 1-mediated MicroRNA decay. Neoplasia. 47. 100963–100963. 2 indexed citations

Cheng, Lulin, Bing Liu, Liang Chen, et al.. (2023). SGK2 promotes prostate cancer metastasis by inhibiting ferroptosis via upregulating GPX4. Cell Death and Disease. 14(1). 74–74. 41 indexed citations

Li, Xuexiang, Yunxue Li, Bing Liu, et al.. (2023). P4HA2 ‐mediated HIF ‐1α stabilization promotes erdafitinib‐resistance in FGFR3 ‐alteration bladder cancer. The FASEB Journal. 37(4). 17 indexed citations

Yu, Ying, Bing Liu, Xuexiang Li, et al.. (2022). ATF4/CEMIP/PKCα promotes anoikis resistance by enhancing protective autophagy in prostate cancer cells. Cell Death and Disease. 13(1). 46–46. 53 indexed citations

Chen, Liang, Yarong Song, Teng Hou, et al.. (2022). Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism. Journal of Experimental & Clinical Cancer Research. 41(1). 194–194. 36 indexed citations

Li, Yunxue, Lulin Cheng, Pu Zhang, et al.. (2022). Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification. Journal of Translational Medicine. 20(1). 202–202. 19 indexed citations

10.

Yu, Ying, Yarong Song, Lulin Cheng, et al.. (2022). CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells. Journal of Experimental & Clinical Cancer Research. 41(1). 188–188. 77 indexed citations

11.

Liu, Bing, Xuexiang Li, Decai Wang, et al.. (2022). CEMIP promotes extracellular matrix‐detached prostate cancer cell survival by inhibiting ferroptosis. Cancer Science. 113(6). 2056–2070. 35 indexed citations

12.

Lu, Dingheng, Yarong Song, Ying Yu, et al.. (2021). KAT2A-mediated AR translocation into nucleus promotes abiraterone-resistance in castration-resistant prostate cancer. Cell Death and Disease. 12(8). 787–787. 30 indexed citations

13.

Liu, Bing, Yarong Song, Ying Yu, et al.. (2021). CEMIP-Mediated ITPR3/CaMKII/NRF2/SLC7A11 Pathway Promotes Ferroptosis Resistance of Prostate Cancer Cells During Extracellular Matrix Detachment. SSRN Electronic Journal. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact